Archived Publications Archives

← ALL PUBLICATIONS

Archived Publications

Discordant Lymphoma Consisting of Mediastinal Large B-Cell Lymphoma and Nodular Sclerosis Hodgkin Lymphoma in the Right Supraclavicular Lymph Nodes: A Case Report

Invivoscribe Marketing2021-02-12T22:24:11-08:00December 29th, 2015|Archived Publications, Publications|

Molecular Genetic Data Favoring a Sequential Clonal Transformation of a Large B Cell Lymphoma into an Anaplastic Large T Cell Lymphoma, ALK-Negative

Invivoscribe Marketing2021-02-12T20:48:04-08:00December 1st, 2015|Archived Publications, Publications|

Mucosal CD30-Positive T-Cell Lymphoproliferative Disorder Arising in the Oral Cavity Following Dental Implants

Invivoscribe Marketing2021-02-12T22:28:17-08:00August 10th, 2015|Archived Publications, Publications|

Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in chronic lymphocytic leukemia

Invivoscribe Marketing2021-02-13T00:38:16-08:00March 18th, 2015|Archived Publications, Publications|

Deep sequencing reveals clonal evolution patterns and mutation events associated with relapse in B-cell lymphomas

Invivoscribe Marketing2021-02-13T00:42:37-08:00August 15th, 2014|Archived Publications, Publications|

Immunoblastic Follicular Lymphoma: A Very Unusual Transformation of Low-Grade Follicular Lymphoma

Invivoscribe Marketing2021-02-13T00:46:19-08:00August 13th, 2014|Archived Publications, Publications|

The evolution of clonality testing in the diagnosis and monitoring of hematological malignancies

Invivoscribe Marketing2021-02-12T20:42:59-08:00April 5th, 2014|Archived Publications, Publications|

Clonality Of Multiple Distinct Lymphoproliferative Disorders Occurring Within Individual HIV+ Patients

Invivoscribe Marketing2021-02-18T21:08:35-08:00November 15th, 2013|Archived Publications, Publications|

Hydroa Vacciniforme-like Lymphoma: A Chronic EBV+ Lymphoproliferative Disorder with Risk to Develop a Systemic Lymphoma

Invivoscribe Marketing2021-02-18T21:10:55-08:00October 31st, 2013|Archived Publications, Publications|

Paediatric and Adolescent Elevated Conjunctival Lesions in the Plical Area: Lymphoma or Reactive Lymphoid Hyperplasia?

Invivoscribe Marketing2021-02-18T21:14:44-08:00October 25th, 2013|Archived Publications, Publications|

Diagnostic Utility of a Clonality Test for Lymphoproliferative Diseases in Koreans Using the BIOMED-2 PCR Assay

Invivoscribe Marketing2021-02-18T21:18:36-08:00October 25th, 2013|Archived Publications, Publications|

Dried Blood Spot Sampling for Detection of Monoclonal Immunoglobulin Gene Rearrangement

Invivoscribe Marketing2021-02-18T21:22:32-08:00August 13th, 2013|Archived Publications, Publications|

EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations

Invivoscribe Marketing2021-02-18T21:25:10-08:00October 26th, 2012|Archived Publications, Publications|

A Practical Approach to Diagnostic Ig/TCR Clonality Evaluation in Clinical Pathology

Invivoscribe Marketing2021-02-18T22:35:18-08:00January 11th, 2012|Archived Publications, Publications|

Multiple Clonal Ig/TCR Products: Implications for Interpretation of Clonality Findings

Invivoscribe Marketing2021-02-18T22:37:16-08:00December 10th, 2011|Archived Publications, Publications|

Application of cost–effectiveness analysis to demonstrate the potential value of companion diagnostics in chronic myeloid leukemia

Invivoscribe Marketing2021-02-18T22:40:02-08:00March 30th, 2011|Archived Publications, Publications|

Molecular Diagnostics of Hematologic Malignancies

Invivoscribe Marketing2021-02-18T22:44:51-08:00September 2nd, 2009|Archived Publications, Publications|

IMGT/GeneInfo: T cell receptor gamma TRG and delta TRD genes in database give access to all TR potential V(D)J recombinations

Invivoscribe Marketing2021-02-18T22:47:08-08:00April 26th, 2006|Archived Publications, Publications|

IMGT/JunctionAnalysis: the first tool for the analysis of the immunoglobulin and T cell receptor complex V–J and V–D–J JUNCTIONs

Invivoscribe Marketing2021-02-18T22:53:47-08:00August 4th, 2004|Archived Publications, Publications|

The Laboratory for Personalized Molecular Medicine® (LabPMM®) at Invivoscribe offer internationally standardized testing of novel and proprietary biomarkers that are critically important for patient care.

Lymphoma

Myeloma

Browse our comprehensive menu of product & testing services.

A proven strategy to accelerate drug approvals

CE-IVD

Design Controls, Bioinformatics Software, Identify & Track, Custom Development, and Complementary MRD Assays

CE-IVD

cGMP Compliant, CE-marked IVDs & CDx Manufacturing, Assay Development, and Controls & Reagents

Clinical Lab Experience, Internationally Standardized, Comprehensive Panels, Complementary MRD Assays, and Worldwide Enrollment

Accredited & Proven, Registered Medical Device Establishment, Multiple CDx Approvals, CE-marked IVDs, and Marketing Authorization Holder (MAH)

We take pride in expanding the science that bridges personalized medicine with quality healthcare.

Personalized Molecular Medicine® is use of genomics and patient specific information to identify optimal treatment for each patient.

Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid Leukemia

Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid Leukemia

Assessment of Bone Marrow Involvement in B-Cell non-Hodgkin Lymphoma Using Immunoglobulin Gene Rearrangement Analysis with Next-Generation Sequencing

Evaluation of Next-Generation Sequencing Versus Next-Generation Flow Cytometry for Minimal Residual Disease Detection in Chinese Patients with Multiple Myeloma

Lymphoma

Myeloma

Lymphoma

Myeloma

Browse our comprehensive menu of product & testing services.

The Laboratory for Personalized Molecular Medicine^® (LabPMM^®) at Invivoscribe offer internationally standardized testing of novel and proprietary biomarkers that are critically important for patient care.

Personalized Molecular Medicine^® is use of genomics and patient specific information to identify optimal treatment for each patient.